Post-Traumatic Stress Disorder Treatment Market Growth, Size, Trends, Demand and Future Scope

Post-Traumatic Stress Disorder Treatment Market Size – By Drug Type, By Age Group, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Post-Traumatic Stress Disorder Treatment Market Size – By Drug Type, By Age Group, By Distribution Channel, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Published: Dec 2022 Report ID: HLCA2234 Pages: 1 - 232 Formats*:     
Category : Healthcare
Post-Traumatic Stress Disorder Treatment Market Introduction and Overview 

According to SPER Market Research, the Global Post-Traumatic Stress Disorder Treatment Market is estimated to reach USD 27.77 billion by 2032 with a CAGR of 5.14%.

The report includes an in-depth analysis of the Global Post-Traumatic Stress Disorder Treatment market, including market size and trends, product mix, distribution channels, and supplier analysis. Post-traumatic stress disorder (PTSD) can occur in persons who have encountered a significant shock, such as a natural disaster, a life-threatening event, a vehicle accident, sexual abuse, and so on. PTSD symptoms can appear three months or even a year later. Most PTSD patients have symptoms such as intrusive memories, avoidance, negative thinking changes, and altered emotional and physical responses. For example, the sudden death of a loved one may trigger PTSD in some people.

  • At Biomed Israel, Madrigal Mental Care demonstrated its nanotechnology for the treatment and prevention of post-traumatic stress disorder.
  • Mydecine Innovations Group Inc. partnered with Combat Stress and King's College London to treat post-traumatic stress disorder (PTSD) in veterans by using psilocybin in psychoactively aided psychotherapy.
Post-Traumatic Stress Disorder Treatment Market
Market Opportunities and Challenges
The Post-Traumatic Stress Disorder Treatment market has a variety of opportunities and challenges. On the opportunity side, the key factors driving the growth of the post-traumatic stress disorder treatment market are an increase in the prevalence of post-traumatic stress disorder globally, an increase in the number of clinical trials related to the treatment of post-traumatic stress disorder, and an increase in research and development efforts aimed at introducing novel therapies and medications. Furthermore, the market is expected to grow due to various factors, including the growing prevalence of post-traumatic stress disorder (PTSD) globally, an increase in clinical trials for PTSD treatment, and an increase in research and development of new therapies and medications for PTSD.

The high cost of care places significant restrictions on the market for post-traumatic stress disorder treatment. Post-traumatic stress disorder (PTSD) is becoming more commonplace worldwide, more clinical research is being done to treat PTSD, and more new PTSD therapies and drugs are being developed; all of these factors have led to the market's growth. Furthermore, the other obstacles impeding the growth of the post- Traumatic Stress Disorder treatment market, however, are the adverse effects of treatment for post-traumatic stress disorder and its high cost.

Post-Traumatic Stress Disorder Treatment Market


Market Competitive Landscape
The market for treatments for post-traumatic stress disorder is crowded, with many domestic and foreign competitors. To improve their market presence, the major players are implementing a variety of growth tactics, including alliances, partnerships, joint ventures, new product launches, geographic expansions, mergers, and acquisitions. Lupin Limited, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc, and Merck KGaA are a few of the major companies in the industry.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2032
 Base year considered 2021
 Forecast period 2022-2032
 Segments coveredBy Drug Type, By Age Group, By Distribution Channel, By End User
 Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa
 Companies CoveredAllergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd. 
COVID-19 Impact on Global Post-Traumatic Stress Disorder Treatment Market
The market for posttraumatic stress disorder (PTSD) treatment has been severely affected by the COVID-19 pandemic, an unprecedented health hazard. Numerous research have demonstrated that COVID-19 raises the risk of PTSD, and as a result, there is a growing need for PTSD treatment. For example, a review article published in August 2021 titled "COVID-19 and Posttraumatic Stress Disorder: The Perfect 'Storm' for Mental Health (Review)" showed that COVID-19 has a major effect on mental health and increases the risk of developing trauma-related disorders, including PTSD, in those who are most susceptible, such as children, adolescents, and adult COVID-19 survivors.

Key Target Audience
  • Hospitals
  • Mental Health Centre
  • Outpatient Clinics
Our in-depth analysis of the Post-Traumatic Stress Disorder Treatment Market includes the following segments:
By Drug Type:
  • Anti-anxiety
  • Antidepressants
  • Antipsychotics
  • Beta-blockers
  • Monoamine Oxidase
  • Others
  • By Age Group:
  • Paediatrics
  • Geriatrics
  • Adults
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By End User:
  • Mental Health Center
  • Hospitals
  • Outpatient Clinics
  • Others
  • By Region:
  • Asia-Pacific
  • Europe
  • Middle East & Africa
  • North America
  • South America
  • Key Topics Covered in the Report
    • Global Post-Traumatic Stress Disorder Treatment Market Size (FY’2022-FY’2032)
    • Overview of Global Post-Traumatic Stress Disorder Treatment Market
    • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Drug Type (Anti-anxiety, Antidepressants, Antipsychotics, Beta-blockers, Monoamine Oxidase, Others)
    • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Age Group (Paediatrics, Geriatrics, Adults)
    • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • Segmentation of Global Post-Traumatic Stress Disorder Treatment Market By End User (Mental Health Centre, Hospitals, Outpatient Clinics, Others) Statistical Snap of Global Post-Traumatic Stress Disorder Treatment Market
    • Expansion Analysis of Global Post-Traumatic Stress Disorder Treatment Market
    • Problems and Obstacles in Global Post-Traumatic Stress Disorder Treatment Market
    • Competitive Landscape in the Global Post-Traumatic Stress Disorder Treatment Market
    • Impact of COVID-19 and Demonetization on Global Post-Traumatic Stress Disorder Treatment Market
    • Details on Current Investment in Global Post-Traumatic Stress Disorder Treatment Market
    • Competitive Analysis of Global Post-Traumatic Stress Disorder Treatment Market
    • Prominent Players in the Global Post-Traumatic Stress Disorder Treatment Market
    • SWOT Analysis of Global Post-Traumatic Stress Disorder Treatment Market
    • Global Post-Traumatic Stress Disorder Treatment Market Future Outlook and Projections (FY’2022-FY’2032)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1 Research data source
    2.1.1 Secondary data
    2.1.2 Primary data
    2.1.3 SPER’s internal database
    2.1.4 Premium insight from KOL’s
    2.2 Market size estimation
    2.2.1 Top-down and Bottom-up approach
    2.3 Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1 Drivers
    4.1.2 Restraints
    4.1.3 Opportunities
    4.1.4 Challenges 
    4.2. COVID-19 Impacts of the Global Post-Traumatic Stress Disorder Treatment Market 

    5. Market variables and outlook
    5.1. SWOT analysis 
    5.1.1 Strengths 
    5.1.2 Weaknesses 
    5.1.3 Opportunities
    5.1.4 Threats
    5.2. PESTEL analysis 
    5.2.1 Political landscape
    5.2.2 Economic landscape
    5.2.3 Social landscape 
    5.2.4 Technological landscape 
    5.2.5 Environmental landscape 
    5.2.6 Legal landscape 
    5.3. PORTER’S five forces analysis 
    5.3.1 Bargaining power of suppliers 
    5.3.2 Bargaining power of Buyers 
    5.3.3 Threat of Substitute 
    5.3.4 Threat of new entrant 
    5.3.5 Competitive rivalry
    5.4. Heat map analysis

    6. Competitive Landscape 
    6.1 Global Post-Traumatic Stress Disorder Treatment Manufacturing Base Distribution, Sales Area, Product Type 
    6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Post-Traumatic Stress Disorder Treatment Market 

    7. Global Post-Traumatic Stress Disorder Treatment Market, By DrugType, 2019-2032 (USD Million)
    7.1 Anti-anxiety
    7.2 Antidepressants
    7.3 Antipsychotics
    7.4 Beta-blockers
    7.5 Monoamine Oxidase
    7.6 Others

    8. Global Post-Traumatic Stress Disorder Treatment Market, By Age Group, 2019-2032 (USD Million)
    8.1 Paediatrics
    8.2 Geriatrics
    8.3 Adults

    9. Global Post-Traumatic Stress Disorder Treatment Market, By Distribution Channel, 2019-2032 (USD Million)
    9.1 Hospital Pharmacies
    9.2 Retail Pharmacies
    9.3 Online Pharmacies

    10.  Global Post-Traumatic Stress Disorder Treatment Market, By End User, 2019-2032 (USD Million)
    10.1 Mental Health Center
    10.2 Hospitals
    10.3 Outpatient Clinics
    10.4 Others

    11. Global Post-Traumatic Stress Disorder Treatment Market, By Region, 2019-2032 (USD Million)
    11.1 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2019-2025) 
    11.2 Global Post-Traumatic Stress Disorder Treatment Size and Market Share by Region (2026-2032)
    11.3 Asia-Pacific
    11.3.1 Australia
    11.3.2 China
    11.3.3 India
    11.3.4 Japan
    11.3.5 South Korea
    11.3.6 Rest of Asia-Pacific
    11.4 Europe
    11.4.1 France
    11.4.2 Germany
    11.4.3 Italy
    11.4.4 Spain
    11.4.5 United Kingdom
    11.4.6 Rest of Europe
    11.5 Middle East & Africa
    11.5.1 Kingdom of Saudi Arabia 
    11.5.2 United Arab Emirates
    11.5.3 Rest of Middle East & Africa
    11.6 North America
    11.6.1 Canada
    11.6.2 Mexico
    11.6.3 United States
    11.7 South America
    11.7.1 Argentina
    11.7.2 Brazil
    11.7.3 Rest of South America

    12. Company Profiles
    12.1 Allergan PLC
    12.1.1 Company details 
    12.1.2 Financial outlook
    12.1.3 Product summary 
    12.1.4 Recent developments

    12.2 Amneal Pharmaceuticals LLC
    12.2.1 Company details 
    12.2.2 Financial outlook
    12.2.3 Product summary 
    12.2.4 Recent developments

    12.3 Apotex Inc.
    12.3.1 Company details 
    12.3.2 Financial outlook
    12.3.3 Product summary 
    12.3.4 Recent developments

    12.4 AstraZeneca
    12.4.1 Company details 
    12.4.2 Financial outlook
    12.4.3 Product summary 
    12.4.4 Recent developments

    12.5 Aurobindo Pharma
    12.5.1 Company details 
    12.5.2 Financial outlook
    12.5.3 Product summary 
    12.5.4 Recent developments

    12.6 Bausch Health Companies Inc.
    12.6.1 Company details 
    12.6.2 Financial outlook
    12.6.3 Product summary 
    12.6.4 Recent developments

    12.7 Bristol-Myers Squibb
    12.7.1 Company details 
    12.7.2 Financial outlook
    12.7.3 Product summary 
    12.7.4 Recent developments

    12.8 Eli Lilly and Company
    12.8.1 Company details 
    12.8.2 Financial outlook
    12.8.3 Product summary 
    12.8.4 Recent developments

    12.9 GlaxoSmithKline PLC
    12.9.1 Company details 
    12.9.2 Financial outlook
    12.9.3 Product summary 
    12.9.4 Recent developments

    12.10 Johnson and Johnson
    12.10.1 Company details 
    12.10.2 Financial outlook
    12.10.3 Product summary 
    12.10.4 Recent developments

    12.11 Mylan Pharmaceuticals
    12.11.1 Company details 
    12.11.2 Financial outlook
    12.11.3 Product summary 
    12.11.4 Recent developments

    12.12 Pfizer Inc.
    12.12.1 Company details 
    12.12.2 Financial outlook
    12.12.3 Product summary 
    12.12.4 Recent developments

    12.13 Sun Pharmaceuticals Pvt Ltd
    12.13.1 Company details 
    12.13.2 Financial outlook
    12.13.3 Product summary 
    12.13.4 Recent developments

    12.14 Teva Pharmaceuticals Industries Ltd.
    12.14.1 Company details 
    12.14.2 Financial outlook
    12.14.3 Product summary 
    12.14.4 Recent developments

    13. List of Abbreviations

    14. Reference Links

    15. Conclusion

    16. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    The Post-Traumatic Stress Disorder Treatment Market is projected to reach USD 27.77 billion by 2032, growing at a CAGR of 5.14% during the forecast period.
    The Post-Traumatic Stress Disorder Treatment Market grew in market size from 2021. The Market is expected to reach USD 27.77 billion by 2032, at a CAGR of 5.14% during the forecast period.
    The Post-Traumatic Stress Disorder Treatment Market CAGR of 5.14% during the forecast period.
    The Post-Traumatic Stress Disorder Treatment Market size is USD 27.77 billion from 2022 to 2032.
    The Post-Traumatic Stress Disorder Treatment Market segment is Covered By Drug Type, By Age Group, By Distribution Channel, By End User.
    The North America region is anticipated to have the highest market share in the Post-Traumatic Stress Disorder Treatment Market.
    The key players in the market include Companies Covered Allergan PLC, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson, Mylan Pharmaceuticals, Pfizer Inc., Sun Pharmaceuticals Pvt Ltd, Teva Pharmaceuticals Industries Ltd.
    The market for treating post-traumatic stress disorder is severely constrained by the high cost of care.The prevalence of post-traumatic stress disorder (PTSD) is rising globally, there are more clinical studies being conducted to treat PTSD, and there has been an increase in the development of new PTSD treatments and medications, all of which have contributed to the market's expansion.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 4250
    • 20% off
               
      $ 5650
    • 25% off
           
      $ 7450
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650